Lantheus Holdings, Inc. Impairment Lessor Asset Under Operating Lease
Lantheus Holdings, Inc. (LNTH) reported Impairment Lessor Asset Under Operating Lease of $9.50 million for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentLessorAssetUnderOperatingLease · last filed 2024-02-22
- Lantheus Holdings, Inc. impairment lessor asset under operating lease for the quarter ending 2021-12-31 was $0.00.
- Lantheus Holdings, Inc. impairment lessor asset under operating lease for the quarter ending 2021-09-30 was $9.50M.
- Lantheus Holdings, Inc. impairment lessor asset under operating lease for fiscal 2021 was $9.50M.
| Period end | Impairment Lessor Asset Under Operating Lease 3 month | Impairment Lessor Asset Under Operating Lease 6 month | Impairment Lessor Asset Under Operating Lease 9 month | Impairment Lessor Asset Under Operating Lease 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $9.50M derived: sum of 2 quarters · filed 2024-02-22 | $9.50M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $9.50M 10-Q · filed 2021-11-04 | $9.50M 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |